Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: no known allergies / adverse drug reactions attending: chief complaint: s/p total hip replacement major surgical or invasive procedure: total hip replacement history of present illness: this is a 74 year old male with pmh significant for htn, cad, diastolic dysfunction, moderate pulmonary hypertension with an estimated pasp of 41 mm hg on last echo in , oa, hyperlipidemia, dm2, who was admitted to the micu for post-operative monitoring following a l tha revision. of note, the patient was recently admitted to from - , during which time he underwent left total hip arthroplasty on . post-operative course was complicated by development of ams, left-sided facial droop, and left sensory neglect. pt was seen by the neurology service at that time and was diagnosed with cva. per report he had good functional recovery with just minimal left sided weakness. he was started on lovenox and following that admission in addition to aspirin 325mg which he was taking previously. . the patient did well after discharge until when he presented to orthopedic clinic following a fall at home. x-rays at that time showed a periprosthetic fracture with the accolade femoral stem rotated and a displaced fracture of the left greater trochanter. he was made non-weight bearing and was scheduled for surgical revision on . it is unclear what blood thinners the patient was on prior to surgery, although it seems that the lovenox had been discontinued a few days prior. it is unclear if and when his aspirin and were discontinued prior to surgery. unfortunately, the surgery was complicated by a large amount of blood loss and hemodynamic instability requiring levophed 0.1 mcg/kg/min and phenylephrine. anesthesia was attempting to wean the phenylephrine prior to transfer to the icu. orthopedics consulted trauma surgery to assist in the or given the amount of bleeding. per omr, he required 12 units of prbcs, 14 units of ffp, and a 6 pack of platelets intraoperatively. he was kept sedated with propofol and small bolus doses of ketamine and fentanyl during the procedure. he remained intubated at time of transfer to the icu. he did not have a central line, but has good peripheral access and an a-line. . on arrival to the micu, initial vs were: t=96.4, p=49, bp=103/61, r=10, o2 sat=100% on vent. patient was intubated, off of sedation, and minimally responsive. phenylephrine was weaned off due to bradycardia to the 30s. past medical history: hypertension, coronary artery disease, osteoarthritis, elevated cholesterol, diabetes, and occasional anxiety; tonsillectomy social history: retired, lives with wife. smoked and does not drink alcohol family history: brother died at age 59 unexpectedly, cause unknown. grandmother with diabetes. physical exam: general: a/o x 3. heent: sclera anicteric, mmm, oropharynx clear neck: supple, jvp not elevated, no lad lungs: clear to auscultation anteriorly, no wheezes, rales, rhonchi cv: bradycardic, 2/6 sem radiating to the left axilla abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding. lbm . gu: condom cath to drainage bag scrotal edema neuro: intact with no focal deficits lle: * incision healing well with staples * thigh full but soft * no calf tenderness * 5/5 strength * silt, nvi distally * toes warm pertinent results: : ct head w/contrast: 1. no acute intracranial hemorrhage. if there is concern for acute infarction, an mri with dwi can be obtained for further evaluation. 2. multiple paranasal sinus disease, likely relates to the endotracheal intubation. 07:00am blood wbc-6.2 rbc-3.20* hgb-9.6* hct-28.8* mcv-90 mch-30.1 mchc-33.4 rdw-15.1 plt ct-201 04:34am blood wbc-7.2 rbc-3.28* hgb-9.9* hct-29.1* mcv-89 mch-30.2 mchc-34.1 rdw-15.8* plt ct-155 05:14am blood wbc-7.4 rbc-2.97* hgb-8.9* hct-26.9* mcv-91 mch-30.0 mchc-33.2 rdw-15.5 plt ct-145* 05:52pm blood wbc-9.7 rbc-3.28* hgb-9.9* hct-28.9* mcv-88 mch-30.2 mchc-34.2 rdw-15.8* plt ct-139* 11:33am blood wbc-9.7 rbc-3.07* hgb-9.3* hct-27.3* mcv-89 mch-30.2 mchc-34.0 rdw-15.7* plt ct-120* 04:23am blood wbc-9.0 rbc-3.16* hgb-9.6* hct-28.2* mcv-89 mch-30.3 mchc-33.9 rdw-15.6* plt ct-103* 10:58pm blood wbc-9.4 rbc-3.16* hgb-9.4* hct-27.9* mcv-89 mch-29.9 mchc-33.8 rdw-15.5 plt ct-100* 05:37pm blood wbc-10.0 rbc-3.45* hgb-10.5* hct-29.8* mcv-86 mch-30.3 mchc-35.1* rdw-15.7* plt ct-105* 12:48pm blood wbc-10.4 rbc-3.54* hgb-10.7* hct-30.8* mcv-87 mch-30.2 mchc-34.8 rdw-15.7* plt ct-97* 03:11am blood wbc-10.0 rbc-3.41* hgb-10.6* hct-30.5* mcv-89 mch-30.9 mchc-34.6 rdw-15.6* plt ct-92* 05:19pm blood wbc-11.8* rbc-3.64* hgb-11.1* hct-31.5* mcv-86 mch-30.4 mchc-35.2* rdw-15.4 plt ct-103* 04:01am blood wbc-9.9 rbc-2.93* hgb-8.9* hct-25.5* mcv-87 mch-30.5 mchc-35.0 rdw-16.3* plt ct-124* 03:51pm blood wbc-10.0# rbc-3.74* hgb-11.2* hct-31.5* mcv-84 mch-29.9 mchc-35.5* rdw-15.9* plt ct-82*# 10:40am blood wbc-5.1 rbc-3.28* hgb-9.6* hct-28.2* mcv-86 mch-29.2 mchc-34.0 rdw-16.3* plt ct-169 09:15am blood wbc-3.7*# rbc-2.69* hgb-7.9* hct-23.8* mcv-88 mch-29.4 mchc-33.3 rdw-16.3* plt ct-233 07:00am blood pt-18.1* ptt-30.7 inr(pt)-1.6* 04:34am blood pt-16.1* ptt-30.1 inr(pt)-1.4* 05:14am blood pt-17.2* ptt-32.8 inr(pt)-1.5* 05:52pm blood pt-16.5* ptt-31.2 inr(pt)-1.5* 04:23am blood pt-14.7* ptt-30.5 inr(pt)-1.3* 07:00am blood glucose-109* urean-14 creat-0.8 na-140 k-3.4 cl-103 hco3-30 angap-10 04:34am blood glucose-116* urean-17 creat-0.8 na-142 k-3.5 cl-107 hco3-29 angap-10 05:14am blood glucose-138* urean-23* creat-0.9 na-144 k-3.7 cl-111* hco3-28 angap-9 05:52pm blood glucose-145* urean-21* creat-1.0 na-144 k-3.9 cl-113* hco3-27 angap-8 04:01am blood alt-6 ast-28 ld(ldh)-242 alkphos-51 totbili-0.4 07:00am blood calcium-8.8 phos-2.9 mg-1.6 04:34am blood calcium-8.5 phos-2.5* mg-1.5* brief hospital course: the patient was admitted to the orthopaedic surgery service and was taken to the operating room for above described procedure. please see separately dictated operative report for details. the surgery was uncomplicated and the patient tolerated the procedure well. patient received perioperative iv antibiotics. postoperative course was remarkable for the following: 1. this is a 74 year old male with pmh significant for htn, cad, diastolic dysfunction, moderate pulmonary hypertension with an estimated pasp of 41 mm hg on last echo in , oa, hyperlipidemia, dm2, who was admitted to the micu post-operatively while still intubated and sedated for hemodynamic monitoring following a left tha revision complicated by a large amount of blood loss and hemodynamic instability requiring two pressors. 2. course: the patient had extensive blood loss requiring 12 units of prbcs, 14 units of ffp, and a 6 pack of platelets. he was also on levophed and phenylephrine to maintain his blood pressures. there was concern for cva or neurogenic shock as his blood pressures have varied widely from 80s-180s systolic, he is bradycardic, however cta head was negative. central line was placed and levophed continued for low pressures. he received another 1 unit of prbc and 1 unit of platelets. he was also noted to have st elevations on ekg likely in setting of demand ischemia related to hypotension and blood loss in setting of cad. patient was extubated pod2. aspirin and held, coumadin was started on pod 3 for dvt ppx. ancef was continued until removal of jp drains on pod3. 3. pod 4 - hct 26.9 -> transfused 1 unit prbcs otherwise, pain was initially controlled with a pca followed by a transition to oral pain medications on pod#1. the patient received lovenox for dvt prophylaxis starting on the morning of pod#1. the foley was removed on pod#2 and the patient was voiding independently thereafter. the surgical dressing was changed on pod#2 and the surgical incision was found to be clean and intact without erythema or abnormal drainage. the patient was seen daily by physical therapy. labs were checked throughout the hospital course and repleted accordingly. at the time of discharge the patient was tolerating a regular diet and feeling well. the patient was afebrile with stable vital signs. the patient's hematocrit was acceptable and pain was adequately controlled on an oral regimen. the operative extremity was neurovascularly intact and the wound was benign. the patient's weight-bearing status is partial (50%) weight bearing on the operative extremity at all times with posterior/trochanter off precautions. mr. is discharged to rehab in stable condition. code: full contact: (wife) (h), (c); (daughter) ; (daughter) medications on admission: 1. enoxaparin 40 mg/0.4 ml syringe sig: one (1) syringe subcutaneous daily (daily). (recently discontinued) 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 3. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day): hold for loose stools. 4. oxycodone 5 mg tablet sig: 1-2 tablets po q3h (every 3 hours) as needed for pain. 5. aspirin, buffered 325 mg tablet sig: one (1) tablet po twice a day for 3 weeks: after completing all lovenox syringes, please take as directed with food. you may resume your preoperative dose after completing this regimen. 6. multivitamin tablet sig: one (1) cap po daily (daily). 7. furosemide 80 mg tablet sig: one (1) tablet po bid (2 times a day). 8. clonidine 0.1 mg tablet sig: two (2) tablet po bid (2 times a day). 9. carvedilol 12.5 mg tablet sig: two (2) tablet po bid (2 times a day). 10. lisinopril 20 mg tablet sig: one (1) tablet po bid (2 times a day). 11. finasteride 5 mg tablet sig: one (1) tablet po daily (daily). 12. simvastatin 40 mg tablet sig: one (1) tablet po daily (daily). 13. metformin 500 mg tablet extended release 24 hr sig: one (1) tablet extended release 24 hr po daily (daily). 14. acetaminophen 325 mg tablet sig: two (2) tablet po q6h (every 6 hours). 15. clopidogrel 75 mg tablet sig: one (1) tablet po daily (daily). 16. clonidine 0.2 mg tablet sig: one (1) tablet po bid (2 times a day): was held on and . discharge medications: 1. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 2. ferrous sulfate 300 mg (60 mg iron) tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 3. multivitamin tablet sig: one (1) tablet po daily (daily). 4. finasteride 5 mg tablet sig: one (1) tablet po daily (daily). 5. simvastatin 40 mg tablet sig: one (1) tablet po daily (daily). 6. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed for constipation. disp:*30 tablet(s)* refills:*0* 7. warfarin 5 mg tablet sig: one (1) tablet po once daily at 4 pm for 6 weeks: goal inr 2-2.5 dr. . disp:*30 tablet(s)* refills:*1* 8. carvedilol 12.5 mg tablet sig: two (2) tablet po bid (2 times a day). 9. furosemide 80 mg tablet sig: one (1) tablet po bid (2 times a day). 10. clonidine 0.2 mg tablet sig: one (1) tablet po bid (2 times a day). 11. oxycodone 5 mg tablet sig: one (1) tablet po q4h (every 4 hours) as needed for pain. disp:*50 tablet(s)* refills:*0* 12. polyethylene glycol 3350 17 gram/dose powder sig: one (1) dose po daily (daily). 13. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po daily (daily). 14. lisinopril 20 mg tablet sig: two (2) tablet po daily (daily). discharge disposition: extended care facility: hospital - discharge diagnosis: l hip greater trochanteric periprosthetic fracture with stem rotation hypotension hypovolemia discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: ambulatory - requires assistance or aid (walker or cane). discharge instructions: 1. please return to the emergency department or notify your physician if you experience any of the following: severe pain not relieved by medication, increased swelling, decreased sensation, difficulty with movement, fevers greater than 101.5, shaking chills, increasing redness or drainage from the incision site, chest pain, shortness of breath or any other concerns. 2. please follow up with your primary physician regarding this admission and any new medications and refills. 3. resume your home medications unless otherwise instructed. 4. you have been given medications for pain control. please do not drive, operate heavy machinery, or drink alcohol while taking these medications. as your pain decreases, take fewer tablets and increase the time between doses. this medication can cause constipation, so you should drink plenty of water daily and take a stool softener (such as colace) as needed to prevent this side effect. call your surgeons office 3 days before you are out of medication so that it can be refilled. these medications cannot be called into your pharmacy and must be picked up in the clinic or mailed to your house. please allow an extra 2 days if you would like your medication mailed to your home. 5. you may not drive a car until cleared to do so by your surgeon or your primary physician. 6. please keep your wounds clean. you may shower starting five (5) days after surgery, but no tub baths or swimming for at least four (4) weeks. no dressing is needed if wound continues to be non-draining. any stitches or staples that need to be removed will be taken out by the visiting nurse (vna) or rehab facility three weeks after your surgery. 7. please call your surgeon's office to schedule or confirm your follow-up appointment in four (4) weeks. 8. please do not take any non-steroidal anti-inflammatory medications (nsaids such as celebrex, ibuprofen, advil, aleve, motrin, etc). 9. anticoagulation: please continue your coumadin for six (6) weeks to help prevent deep vein thrombosis (blood clots). goal inr 2-2.5. stockings x 6 weeks. to be followed by pcp . after discharge from rehab (phone: , fax: ). 10. wound care: please keep your incision clean and dry. it is okay to shower five days after surgery but no tub baths, swimming, or submerging your incision until after your four (4) week checkup. please place a dry sterile dressing on the wound each day if there is drainage, otherwise leave it open to air. check wound regularly for signs of infection such as redness or thick yellow drainage. staples will be removed by the visiting nurse or rehab facility in three (3) weeks. 11. vna (once at home): home pt/ot, dressing changes as instructed, wound checks, and staple removal at three weeks after surgery. 12. activity: partial (50%) weight bearing on operative extremity. posterior and trochanter off precautions. no strenuous exercise or heavy lifting until follow up appointment. physical therapy: lle pwb (50%) at all times 2 crutches or walker at all time posterior/trochanter off precautions mobilize high fall risk treatments frequency: dry sterile dressing daily as needed for drainage wound checks ice as tolerated staple removal pod 21 () - replace with steristrips teds x 6 weeks followup instructions: provider: , : date/time: 11:00 procedure: open reduction of fracture with internal fixation, femur revision of hip replacement, femoral component diagnoses: acidosis congestive heart failure, unspecified unspecified essential hypertension acute posthemorrhagic anemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other chronic pulmonary heart diseases unspecified fall hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) percutaneous transluminal coronary angioplasty status constipation, unspecified other and unspecified hyperlipidemia hemorrhage complicating a procedure old myocardial infarction long-term (current) use of anticoagulants personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation diastolic heart failure, unspecified delirium due to conditions classified elsewhere other closed transcervical fracture of neck of femur other acute and subacute forms of ischemic heart disease, other dislocation of prosthetic joint 

Answer: The patient is high likely exposed to